Humant antimuse- antistof (HAMA) respons er uden prædiktiv værdi for klinisk tolerabilitet baseret på en klinisk undersøgelse af 172 patienter behandlet med basiliximab.
Human antimurine antibody (HAMA) responses were reported in a clinical trial of 172 patients treated with basiliximab, without predictive value for clinical tolerability.